Milestone Pharmaceuticals (NASDAQ:MIST) just reported results for the fourth quarter of 2023.
- Milestone Pharmaceuticals reported earnings per share of -32 cents. This was below the analyst estimate for EPS of -31 cents.
- The company did not report any revenue for the quarter.